Picture of Genus logo

GNS Genus News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

REG - Genus - Additional Listing

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230605:nRSE6449Ba&default-theme=true

RNS Number : 6449B  Genus PLC  05 June 2023

05 June 2023

 

Genus plc

 

Application for Additional Listing

 

Genus plc (LSE: GNS) today announces that an application has been made to the
Financial Conduct Authority and the London Stock Exchange for the admission of
250,000 new ordinary shares of 10p each ('Ordinary Shares') in Genus, which
have been allotted to the Company's Employee Benefit Trust to be used to
satisfy share awards under Genus plc's shareholder-approved share plans.

It is expected that the 250,000 Ordinary Shares will be admitted to trading on
the Official List on 9 June 2023. The shares will rank pari passu with the
existing Ordinary Shares of the Company.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company
Secretary

Tel: +44 (0)1256 347100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ALSSSFSAIEDSEFM

Recent news on Genus

See all news